Evidence map›Paper›PMID 25049333›Full record

ArticleThe Journal of experimental medicine2014

MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage.

Marielle C Gold, James E McLaren, Joseph A Reistetter, Sue Smyk-Pearson, Kristin Ladell, Gwendolyn M Swarbrick, Yik Y L Yu, Ted H Hansen, Ole Lund, Morten Nielsen and 6 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed.

  1. Trial
  2. Article
  3. Avoidance of MAIT cells is an essential determinant ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. ReprogrammingmBio · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Innate immune responses in pneumonia.Pneumonia (Nathan Qld.) · 2023
    Review
  19. Article
  20. Article

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Marielle C GoldDivision of Pulmonary and Critical Care Medicine, Department of Molecular Microbiology and Immunology, and Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239Division of Pulmonary and Critical Care Medicine, Department of Molecular Microbiology and Immunology, and Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239 Portland VA Medical Center, Portland, OR 97239 goldm@ohsu.edu lewinsod@ohsu.edu.
James E McLarenInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, Wales, UK.
Joseph A ReistetterDivision of Pulmonary and Critical Care Medicine, Department of Molecular Microbiology and Immunology, and Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239.
Sue Smyk-PearsonDivision of Pulmonary and Critical Care Medicine, Department of Molecular Microbiology and Immunology, and Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239.
Kristin LadellInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, Wales, UK.
Gwendolyn M SwarbrickDivision of Pulmonary and Critical Care Medicine, Department of Molecular Microbiology and Immunology, and Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239.
Yik Y L YuDepartment of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110.
Ted H HansenDepartment of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110.
Ole LundCenter for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, 2800 Lyngby, Denmark.
Morten NielsenCenter for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, 2800 Lyngby, Denmark Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, 1650 San Martín, Buenos Aires, Argentina.
Bram GerritsenTheoretical Biology and Bioinformatics Group, Utrecht University, 3584 CH Utrecht, Netherlands.
Can KesmirTheoretical Biology and Bioinformatics Group, Utrecht University, 3584 CH Utrecht, Netherlands.
John J MilesInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, Wales, UK QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
Deborah A LewinsohnDivision of Pulmonary and Critical Care Medicine, Department of Molecular Microbiology and Immunology, and Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239Division of Pulmonary and Critical Care Medicine, Department of Molecular Microbiology and Immunology, and Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239.
David A PriceInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, Wales, UK Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
David M LewinsohnDivision of Pulmonary and Critical Care Medicine, Department of Molecular Microbiology and Immunology, and Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239Division of Pulmonary and Critical Care Medicine, Department of Molecular Microbiology and Immunology, and Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239 Portland VA Medical Center, Portland, OR 97239 goldm@ohsu.edu lewinsod@ohsu.edu.

Funding

Human MAIT celis in airway mucosal immune responses to intracellular infectionsU01AI095776 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M. · 2011 to 2015
$8.9M
MR1 BIOCHEMICAL FEATURES AND IMMUNOLOGICAL FUNCTIONSR01AI046553 · NIAID · WASHINGTON UNIVERSITY · PI FREMONT, DAVED H., HOFT, DANIEL F. · 2000 to 2014
$4.6M
NIAID NIH HHS AI046553NIAID NIH HHS R01 AI046553NIAID NIH HHS U01 AI095776NIAID NIH HHS U01 AI095776-01Wellcome Trust 100326
6 · The paper itself

Abstract

Mucosal-associated invariant T (MAIT) cells express a semi-invariant T cell receptor (TCR) that detects microbial metabolites presented by the nonpolymorphic major histocompatibility complex (MHC)-like molecule MR1. The highly conserved nature of MR1 in conjunction with biased MAIT TCRα chain usage is widely thought to indicate limited ligand presentation and discrimination within a pattern-like recognition system. Here, we evaluated the TCR repertoire of MAIT cells responsive to three classes of microbes. Substantial diversity and heterogeneity were apparent across the functional MAIT cell repertoire as a whole, especially for TCRβ chain sequences. Moreover, different pathogen-specific responses were characterized by distinct TCR usage, both between and within individuals, suggesting that MAIT cell adaptation was a direct consequence of exposure to various exogenous MR1-restricted epitopes. In line with this interpretation, MAIT cell clones with distinct TCRs responded differentially to a riboflavin metabolite. These results suggest that MAIT cells can discriminate between pathogen-derived ligands in a clonotype-dependent manner, providing a basis for adaptive memory via recruitment of specific repertoires shaped by microbial exposure.

Indexed as

Amino Acid SequenceAntigens, Differentiation, B-LymphocyteBacteriaCell LineClone CellsComplementarity Determining RegionsGene Rearrangement, alpha-Chain T-Cell Antigen ReceptorHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHumansLigandsMinor Histocompatibility AntigensMolecular Sequence DataMucous MembraneReceptors, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-betaAntigens, Differentiation, B-LymphocyteComplementarity Determining RegionsHistocompatibility Antigens Class IHistocompatibility Antigens Class IIinvariant chainLigandsMinor Histocompatibility AntigensMR1 protein, humanReceptors, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-betaVitamin B Complex

Identifiers

PMID25049333
PMCPMC4113934

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.